Evidence map›Paper›PMID 35007957›Full record

ArticleDrug and alcohol dependence2022

Safer in care: A pandemic-tested model of integrated HIV/OUD care.

Ellen F Eaton, Ashutosh Tamhane, Wesli Turner, James L Raper, Michael S Saag, Karen L Cropsey

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ellen F EatonUniversity of Alabama at Birmingham, Division of Infectious Diseases, 1900 University Boulevard, Tinsley Harrison Tower, Birmingham, AL 35294, USA. Electronic address: eeaton@uab.edu.
Ashutosh TamhaneUniversity of Alabama at Birmingham, Division of Infectious Diseases, 1900 University Boulevard, Tinsley Harrison Tower, Birmingham, AL 35294, USA.
Wesli TurnerUniversity of Alabama at Birmingham, Division of Infectious Diseases, 1900 University Boulevard, Tinsley Harrison Tower, Birmingham, AL 35294, USA.
James L RaperUniversity of Alabama at Birmingham, Division of Infectious Diseases, 1900 University Boulevard, Tinsley Harrison Tower, Birmingham, AL 35294, USA.
Michael S SaagUniversity of Alabama at Birmingham, Division of Infectious Diseases, 1900 University Boulevard, Tinsley Harrison Tower, Birmingham, AL 35294, USA.
Karen L CropseyUniversity of Alabama at Birmingham, Division of Psychiatry and Behavioral Neurobiology, SC 560, 1720 2nd Ave S, Birmingham, AL 35294-0017, USA.
University of Alabama at Birmingham · US

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
HIV+ Service delivery and Telemedicine through Effective PROsR01MH124633 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI EATON, ELLEN FLORENCE · 2020 to 2024
$3.3M
NIAID NIH HHS P30 AI027767NIMH NIH HHS R01 MH124633
6 · The paper itself

Abstract

backgroundRural, poor, persons with HIV (PWH) and substance use are among the most vulnerable to SARS-CoV-2 and related health service disruptions. The objective of the study was to evaluate the health outcomes and utilization of PWH at an Outpatient-based Opioid Treatment (OBOT) Clinic.

methodsWe evaluated a clinic-based cohort at the University of Alabama at Birmingham HIV clinic from November 2018 to May 2021. We compared HIV outcomes of OBOT patients, who are highly vulnerable, to the overall clinic. We stratified OBOT patients according to comorbid stimulant use disorder and compared clinic utilization and viral load suppression in the 6 months before and after the safer at home mandate (May 2020) in Alabama.

resultsOf 3857 PWH, 57 were referred to OBOT, 48 attended, 45 were initiated on buprenorphine, and 35 had a VL< 200 in the last 6 months. Relative to the overall HIV clinic, OBOT patients were significantly less likely to remain VL suppressed (90% vs 78%, p = 0.01). More patients were suppressed after OBOT linkage (81%) than prior (73%). For those referred before May 2020, there was no change in viral suppression before and after the safer at home order (75%). Although new OBOT referrals did not increase during the pandemic, the number of visits attended per month did increase from a median of 3-4 per patient.

conclusionsUnlike many PWH who faced access barriers, PWH receiving care at OBOT did not fall out of care but increased healthcare utilization and maintained viral suppression despite the public health emergency.

Indexed as

BuprenorphineCOVID-19HIV InfectionsOpioid-Related DisordersHumansOpiate Substitution TreatmentPandemicsSARS-CoV-2BuprenorphineHIVOpioid continuum of careOpioid use disorderSARS-CoV-2

Identifiers

PMID35007957
PMCPMC9758363
OpenAlexW4200156678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.